换一批
换一批Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
第一作者：
Christine B,Turley
第一单位：
Atrium Health Wake Forest School of Medicine, Charlotte, NC, United States.
作者：
Christine B,Turley [1]
;
LaKesha,Tables [2]
;
Trevon,Fuller [3]
;
Lisa J,Sanders [4]
;
Hyman,Scott [5]
;
Amaran,Moodley [6]
;
Amanda,Woodward Davis [7]
;
Brett,Leav [8]
;
Jacqueline,Miller [8]
;
Kathryn,Schoemaker [9]
;
An,Vandebosch [10]
;
Jerald,Sadoff [10]
;
Wayne,Woo [11]
;
Iksung,Cho [11]
;
Lisa M,Dunkle [11]
;
Sijia,Li [12]
;
Lars,van der Laan [12]
;
Peter B,Gilbert [7]
;
Dean,Follmann [13]
;
Holly,Jaynes [7]
;
James G,Kublin [7]
;
Lindsey R,Baden [14]
;
Paul,Goepfert [15]
;
Karen,Kotloff [16]
;
Cynthia L,Gay [17]
;
Ann R,Falsey [18]
;
Hana M,El Sahly [19]
;
Magdalena E,Sobieszczyk [20]
;
Yunda,Huang [7]
;
Kathleen M,Neuzil [16]
;
Lawrence,Corey [7]
;
Beatriz,Grinsztejn [21]
;
Glenda,Gray [22]
;
Nadine,Rouphael [23]
;
Alex,Luedtke [24]
;
COVID-19 Prevention Network CoVPN
作者单位：
Atrium Health Wake Forest School of Medicine, Charlotte, NC, United States.
[1]
Morehouse School of Medicine, Atlanta, GA, United States.
[2]
Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, RJ, Brazil.
[3]
University of South Florida Morsani College of Medicine, Tampa, FL, United States.
[4]
San Francisco Department of Public Health, San Francisco, CA, United States.
[5]
Division of Infectious Diseases, University of California San Diego and Rady Children's Hospital, San Diego, CA, United States.
[6]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
[7]
Moderna Inc., Cambridge, MA, United States.
[8]
Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
[9]
Janssen Vaccines and Prevention, Leiden, the Netherlands.
[10]
Novavax, Gaithersburg, MD, United States.
[11]
Department of Biostatistics, University of Washington, Seattle, WA, United States.
[12]
Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States.
[13]
Brigham and Women's Hospital, Boston, MA, United States.
[14]
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
[15]
Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
[16]
Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
[17]
Department of Medicine, Infectious Disease Division, University of Rochester, Rochester, NY, United States.
[18]
Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, United States.
[19]
Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States.
[20]
Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
[21]
Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council, Cape Town, South Africa.
[22]
Hope Clinic, Emory University, Atlanta, GA, United States.
[23]
Department of Biostatistics, University of Washington, Seattle, WA, United States. Electronic address: aluedtke@uw.edu.
[24]
主题词
成年人(Adult);人类(Humans)
DOI
10.1016/j.vaccine.2023.06.066
PMID
37385888
发布时间
2024-09-17
- 浏览1
Vaccine
Vaccine
4899-4906页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
